Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Abstract: In recent years, deep learning’s use in medical imaging has grown exponentially. However, one of the biggest problems with training deep learning models is the unavailability of large ...